Is AJG a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The bull case for AJG (AJG) rests on Acquisition-led compounding: Gallagher's core growth engine is a continuous stream of tuck-in mergers, completing dozens of deals per year plus periodic large transactions. Revenue (TTM) is ~$13 billion. If you believe that thesis holds, the real questions become position sizing and overlap, not timing. The main risk to that view: The most cited concern is valuation, as AJG often trades at a large premium to the broader insurance sector and to some peers, leaving little room for disappointment. Whether AJG is a buy comes down to whether you believe the thesis. This is informational, not a recommendation, and Walnut is not an investment adviser.
Arthur J. Gallagher & Co. is a global insurance brokerage, risk management, and consulting firm, ranking as the third-largest publicly traded insurance broker behind Marsh & McLennan and Aon. Its Brokerage segment places property, casualty, employee benefits, wholesale, and reinsurance coverage for businesses and institutions, earning commissions and fees, while its Risk Management segment (Gallagher Bassett) handles third-party claims administration. The company runs an asset-light, fee-and-commission model that generates strong free cash flow, and it has built a decades-long track record of growing by acquiring smaller regional brokers and folding them into its platform. The investment picture centers on a proven compounding machine. AJG has posted many consecutive quarters of double-digit adjusted earnings growth, driven by roughly 5% to 6% organic revenue growth plus a large and steady M&A pipeline, capped recently by its transformational AssuredPartners acquisition. The trade-off is valuation: the stock typically trades at a meaningful premium to the broader insurance sector and to some peers, reflecting its consistency and growth. Bulls point to durable demand, pricing power, and synergy potential; skeptics focus on integration risk on larger deals, softening property insurance pricing, and the high multiple.
What's the case for buying AJG?
1. Acquisition-led compounding
Gallagher's core growth engine is a continuous stream of tuck-in mergers, completing dozens of deals per year plus periodic large transactions. In early 2026 it closed nine tuck-ins in a single quarter and reported a pipeline of over 40 term sheets, giving it a long runway to keep adding acquired revenue on top of organic growth.
2. AssuredPartners integration and synergies
The AssuredPartners deal is described as the largest in the insurance brokerage industry's history and materially expanded Gallagher's retail property-casualty footprint. Management targets up to roughly $160 million in run-rate synergies by the end of 2026, so execution on that integration is a key swing factor for margins and earnings.
3. Durable organic growth
Gallagher has guided to full-year 2026 organic revenue growth around 5% to 6%, supported by new business, retention, and exposure increases across retail, wholesale, reinsurance, and benefits. Gallagher Bassett's risk management arm has been posting double-digit revenue growth, adding a second, less pricing-sensitive engine.
4. Strong cash generation and rising dividend
The fee-and-commission model is asset-light and throws off substantial free cash flow, which funds both the acquisition program and a steadily growing dividend. That combination of reinvestment plus shareholder returns is central to the long-term compounding thesis.
What are the risks to AJG?
The most cited concern is valuation, as AJG often trades at a large premium to the broader insurance sector and to some peers, leaving little room for disappointment. Larger acquisitions such as AssuredPartners carry integration, cultural, and technology-system risk that could delay synergies. Softening property insurance pricing could trim organic growth by up to about a percentage point if it continues. Regulatory scrutiny is a growing factor, including Department of Justice attention to roll-up M&A strategies and new federal rules requiring more granular disclosure of broker commissions. Benefits-related exposure to Medicare Advantage payment rates and general economic sensitivity of client exposures round out the risk set.
How is AJG valued? (as of July 2026)
Snapshot for AJG as of July 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Market cap: ~$56 billion
- Revenue (TTM): ~$13 billion
- Q1 2026 revenue: ~$4.76 billion
- Q1 2026 adjusted EPS: ~$4.47
- Trailing P/E: ~35-40x
- Dividend yield: ~1%
AJG reported roughly 28% total revenue growth in Q1 2026, blending about 5% organic growth with large contributions from acquisitions including AssuredPartners. The stock's trailing P/E in the mid-30s to around 40x sits well above the broader insurance industry average, a premium the market has historically assigned to its consistency. Forward multiples look lower on expected earnings growth, but the shares clearly price in continued execution.
How do you decide if AJG is a buy?
Rather than asking whether AJG is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold AJG indirectly through an index or sector ETF before adding more.
For the full picture, see the AJG stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about AJG against your real portfolio and see your actual exposure before deciding.
The bottom line on AJG
The bottom line: AJG's story right now is Acquisition-led compounding, with revenue (ttm) at ~$13 billion. If you believe that narrative continues, the call is about sizing AJG sensibly and checking overlap with what you own; if you doubt it (the risk: the most cited concern is valuation, as AJG often trades at a large premium to the broader insurance sector and to some peers, leaving little room for disappointment.), it is not for you. Decide from the thesis, not the ticker. Walnut is not an investment adviser.
Build a basket around AJG with Walnut
Use AJG as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is AJG a good stock to buy right now?
+
The case for AJG right now is Acquisition-led compounding, with revenue (ttm) at ~$13 billion. If you believe that thesis holds, AJG is a way to own it and the real questions are sizing and overlap, not timing; the main risk to that view is the most cited concern is valuation, as AJG often trades at a large premium to the broader insurance sector and to some peers, leaving little room for disappointment. So it comes down to whether you believe the thesis. Walnut is not an investment adviser and this is not a recommendation.
What does AJG do?
+
Arthur J.
What are the main risks of AJG?
+
The most cited concern is valuation, as AJG often trades at a large premium to the broader insurance sector and to some peers, leaving little room for disappointment. Larger acquisitions such as AssuredPartners carry integration, cultural, and technology-system risk that could delay synergies. Softening property insurance pricing could trim organic growth by up to about a percentage point if it continues. Regulatory scrutiny is a growing factor, including Department of Justice attention to roll-up M&A strategies and new federal rules requiring more granular disclosure of broker commissions. Benefits-related exposure to Medicare Advantage payment rates and general economic sensitivity of client exposures round out the risk set.
What does Arthur J. Gallagher do?
+
It is a global insurance brokerage and risk management firm. It helps businesses and institutions buy insurance coverage, earning commissions and fees, and its Gallagher Bassett arm administers claims. It does not primarily underwrite insurance itself, which keeps the model asset-light.
How does AJG make money?
+
Most revenue comes from commissions and fees on the insurance policies it places for clients, plus fees for risk management and claims administration services. Because it brokers rather than underwrites, it avoids most direct insurance claims risk and generates strong recurring cash flow.
Why does AJG trade at such a high valuation?
+
The market has historically paid a premium for AJG's long record of consistent double-digit earnings growth, mid-single-digit organic growth, and a reliable acquisition pipeline. Its trailing P/E often sits well above the broader insurance sector, reflecting that consistency rather than deep value.
What is the AssuredPartners acquisition?
+
AssuredPartners is a large retail insurance brokerage that Gallagher agreed to acquire in a deal described as the largest in the brokerage industry's history. It significantly expands Gallagher's retail property-casualty footprint, with management targeting up to roughly $160 million of run-rate synergies by the end of 2026.
Walnut is informational and is not an investment adviser. This page is educational and not a recommendation to buy or sell AJG; figures are approximate and dated, and your own situation, time horizon, and risk tolerance should drive any decision. Verify current data before investing.